Why the study?
Does pretreatment with propranolol and its stereoisomers inhibit epinephrine-induced ischemic ECG changes?
Does pretreatment with propranolol and its stereoisomers inhibit epinephrine-induced ischemic ECG changes?
Propranolol inhibits epinephrine-induced ischemic ECG changes, suggesting these changes represent a beta-adrenergic response, with L-propranolol being approximately three times as potent as D-propranolol.
Answers are grounded in this paper and cite their sources.
Animal data on propranolol stereoisomers remain hypothesis-generating; human trials needed before any clinical consideration.
Isoproterenol, epinephrine, and norepinephrine, intracoronarily injected with the coronary artery catheterization, produced a. marked "ischemic" change in ECG, while phenylephrine failed to do so. This change was inhibited by the pretreatment with propranolol, but not by that with phenoxybenzamine. No marked change was produced in the coronary blood flow by these catecholamines, but a change occurred in blood pressure pulse pattern recordable from the carotid artery in association with ECG changes. When the magnitude of the "ischemic" change in ECG produced by graded-dose administration of epinephrine was quantitated in terms of ST·T-Area, it was found that the change in ST·T-Area depended on the dose of epinephrine used; norepinephrine produced changes in ECG with nearly equal potency to epinephrine. ECG changes caused by epinephrine in dose of 1 μg was completely inhibited by the pretreatment with about 125 μg of DL-propranolol, L-propranolol or ICI 50172, but 400 μg of D-propranolol was required to produce the same blocking effect. On the other hand, procaine had no such inhibitory effect. From these results it is suggested that the epinephrine-induced ECG changes of "ischemic" type appear to represent a beta-adrenergic response. When the ST and T changes were quantitated in terms of ST·T-Area, propranolol exerted a blocking action on such epinephrine-induced ECG changes, and D-propranolol was one third as potent in this respect as L-propranolol.
No takes yet. Share an insight, caveat, or question.
Hayase et al. (1972) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: